trovafloxacin has been researched along with Pneumococcal Infections in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (50.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Cimochowski, CR; Faiella, JA; Girard, AE; Girard, D; Gootz, TD | 1 |
| Azoulay-Dupuis, E; Bauchet, J; Bédos, JP; Carbon, C; Muffat-Joly, M; Rieux, V | 1 |
| Baldwin, RJ; Léophonte, P; Pluck, N | 1 |
| Deschilder, I; Liekens, K; Lontie, M | 1 |
| Doern, GV; Jones, RN; Pfaller, MA | 1 |
| Banevicius, MA; Lacy, MK; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
| Hershberger, E; Rybak, MJ | 1 |
| Aguilar, L; Alou, L; Fuentes, F; Giménez, MJ; Marco, F; Prieto, J | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Neftel, K; Täuber, MG | 1 |
| Siegel, M; Timpone, J | 1 |
| Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G | 1 |
| Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M | 1 |
| Mendes, CM; Nicodemo, AC; Oplustil, CP; Sinto, S | 1 |
1 review(s) available for trovafloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Penicillin-resistant Streptococcus pneumoniae endocarditis: a case report and review.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Endocarditis, Bacterial; Female; Fluoroquinolones; Humans; Middle Aged; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2001 |
1 trial(s) available for trovafloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Bronchitis; Chlamydia Infections; Chronic Disease; Drug Therapy, Combination; Female; Fluoroquinolones; Haemophilus Infections; Humans; Male; Middle Aged; Naphthyridines; Pneumococcal Infections | 1998 |
12 other study(ies) available for trovafloxacin and Pneumococcal Infections
| Article | Year |
|---|---|
Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1995 |
In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.
Topics: Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Escherichia coli Infections; Female; Fluoroquinolones; Male; Mice; Naphthyridines; Pneumococcal Infections | 1995 |
Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Drug Resistance, Multiple; Female; Fluoroquinolones; Half-Life; Leukopenia; Lung; Mice; Naphthyridines; Penicillins; Pneumococcal Infections; Pneumonia; Streptococcus pneumoniae | 1998 |
In vitro activity of newer quinolones on Streptococcus pneumoniae isolated from outpatients.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Cephalosporins; Doxycycline; Drug Therapy, Combination; Fluoroquinolones; Humans; Naphthyridines; Ofloxacin; Outpatients; Penicillin G; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Roxithromycin; Streptococcus pneumoniae | 1998 |
Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Blood; Cerebrospinal Fluid; Drug Resistance, Microbial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Pharynx; Pneumococcal Infections; Population Surveillance; Respiratory Tract Infections; Sputum; Streptococcus pneumoniae | 1998 |
Protective effect of trovafloxacin, ciprofloxacin and ampicillin against Streptococcus pneumoniae in a murine sepsis model.
Topics: Ampicillin; Animals; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Mice; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1999 |
Activities of trovafloxacin, gatifloxacin, clinafloxacin, sparfloxacin, levofloxacin, and ciprofloxacin against penicillin-resistant Streptococcus pneumoniae in an in vitro infection model.
Topics: Anti-Infective Agents; Blood Coagulation; Ciprofloxacin; Fibrin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2000 |
In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gemifloxacin; Humans; Microbial Sensitivity Tests; Naphthyridines; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2000 |
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration | 2000 |
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 2001 |
In vitro activity of fluoroquinolones (gatifloxacin, levofloxacin and trovafloxacin) and seven other antibiotics against Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Gatifloxacin; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae | 2001 |